The Association of Serum AIM2 Level with the Prediction and Short-Term Prognosis of Coronary Artery Disease

Table 4

Clinical outcomes between two groups.

Outcomes variables (, %)	Groups by AIM2 cut-off value (ng/mL)		value
	Low (≤4.9, )	High (>4.9, )
MACEs	6 (8.2)	21 (19.1)	0.042
Cardiogenic death	0 (0.0)	2 (1.8)	0.518
Nonfatal MI	2 (2.7)	5 (4.5)	0.818
TVR	0 (0.0)	2 (1.8)	0.518
HF	3 (4.1)	9 (8.2)	0.433
Nonfatal stroke	1 (1.4)	3 (2.7)	0.921

AIM2: absent in melanoma 2; MACEs: major adverse cardiovascular events; MI: myocardial infarction; TVR: target vessel revascularization; HF: heart failure.